NO20002343D0 - FremgangsmÕte for Õ potensiere intravenøs estramustinfosfat - Google Patents

FremgangsmÕte for Õ potensiere intravenøs estramustinfosfat

Info

Publication number
NO20002343D0
NO20002343D0 NO20002343A NO20002343A NO20002343D0 NO 20002343 D0 NO20002343 D0 NO 20002343D0 NO 20002343 A NO20002343 A NO 20002343A NO 20002343 A NO20002343 A NO 20002343A NO 20002343 D0 NO20002343 D0 NO 20002343D0
Authority
NO
Norway
Prior art keywords
potentiating
procedure
estramustine phosphate
intravenous estramustine
intravenous
Prior art date
Application number
NO20002343A
Other languages
English (en)
Other versions
NO20002343L (no
Inventor
Michael S Kopreski
Beryl Asp
Bo Fredholm
Per-Olav Gunnarsson
Original Assignee
Upjohn Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Upjohn Co filed Critical Upjohn Co
Publication of NO20002343D0 publication Critical patent/NO20002343D0/no
Publication of NO20002343L publication Critical patent/NO20002343L/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/08—Solutions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
NO20002343A 1998-03-27 2000-05-04 FremgangsmÕte for Õ potensiere intravenøs estramustinfosfat NO20002343L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US7954298P 1998-03-27 1998-03-27
PCT/US1999/004275 WO1999049869A1 (en) 1998-03-27 1999-03-26 Methods to potentiate intravenous estramustine phosphate

Publications (2)

Publication Number Publication Date
NO20002343D0 true NO20002343D0 (no) 2000-05-04
NO20002343L NO20002343L (no) 2000-05-04

Family

ID=22151209

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20002343A NO20002343L (no) 1998-03-27 2000-05-04 FremgangsmÕte for Õ potensiere intravenøs estramustinfosfat

Country Status (16)

Country Link
EP (1) EP1003521A4 (no)
JP (1) JP2001508810A (no)
KR (1) KR20010021656A (no)
CN (2) CN1273530A (no)
AU (1) AU750010B2 (no)
BR (1) BR9906425A (no)
CA (1) CA2295049A1 (no)
EA (1) EA004647B1 (no)
HU (1) HUP0200547A3 (no)
ID (1) ID24504A (no)
IL (1) IL133612A0 (no)
NO (1) NO20002343L (no)
NZ (1) NZ501987A (no)
PL (1) PL342969A1 (no)
WO (1) WO1999049869A1 (no)
ZA (1) ZA997821B (no)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0003201D0 (en) * 2000-02-11 2000-04-05 Pharmacia & Upjohn Spa Method to potentiate the therapeutic efficacy of taxane and derivatives thereof
US6436913B1 (en) * 2000-07-25 2002-08-20 Pharmacia & Upjohn Company Use of estramustine phosphate in the treatment of bone metastasis
RU2471511C1 (ru) * 2011-05-04 2013-01-10 Федеральное государственное бюджетное учреждение "Ростовский научно-исследовательский онкологический институт" Министерства здравоохранения и социального развития Российской Федерации (ФГБУ "РНИОИ" Минздравсоцразвития России) Способ лечения метастазов в печень рака толстой кишки

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS617292A (ja) * 1984-06-20 1986-01-13 Japan Atom Energy Res Inst 制癌剤を結合させたエストラサイト系化合物を製造する方法
US5077056A (en) * 1984-08-08 1991-12-31 The Liposome Company, Inc. Encapsulation of antineoplastic agents in liposomes
MX9203808A (es) * 1987-03-05 1992-07-01 Liposome Co Inc Formulaciones de alto contenido de medicamento: lipido, de agentes liposomicos-antineoplasticos.
DK0706373T3 (da) * 1992-03-23 2000-09-18 Univ Georgetown Liposomindkapslet taxol og en fremgangsmåde til anvendelse heraf
FR2697752B1 (fr) * 1992-11-10 1995-04-14 Rhone Poulenc Rorer Sa Compositions antitumorales contenant des dérivés du taxane.

Also Published As

Publication number Publication date
HUP0200547A2 (hu) 2002-07-29
AU3353399A (en) 1999-10-18
PL342969A1 (en) 2001-07-16
CN1636598A (zh) 2005-07-13
CN1273530A (zh) 2000-11-15
EP1003521A4 (en) 2003-07-23
BR9906425A (pt) 2000-07-11
AU750010B2 (en) 2002-07-11
EA004647B1 (ru) 2004-06-24
CA2295049A1 (en) 1999-10-07
ID24504A (id) 2000-07-20
EP1003521A1 (en) 2000-05-31
IL133612A0 (en) 2001-04-30
EA199901081A1 (ru) 2000-12-25
HUP0200547A3 (en) 2003-07-28
JP2001508810A (ja) 2001-07-03
WO1999049869A1 (en) 1999-10-07
NO20002343L (no) 2000-05-04
ZA997821B (en) 2000-08-01
KR20010021656A (ko) 2001-03-15
NZ501987A (en) 2002-10-25

Similar Documents

Publication Publication Date Title
NO991436D0 (no) Tilknytningskobling
DE69933078D1 (de) Stent Aneurismus-Behandlungssystem
NO974554L (no) FremgangsmÕte for behandling av en underjordisk formasjon
TR199800436A3 (tr) Primidin türevlerinin kanserin önlenmesi için kullanilmasi.
IS5949A (is) Setnar bísýklískar afleiður gagnlegar sem miðlar gegn krabbameini
BR9904281B1 (pt) Montagem de distribuição de medicação
DE59903617D1 (de) Patientenkonnektor
NO20004849L (no) Offshoreborings-system
FI980135A0 (fi) Inbyggt system
DE69933079D1 (de) Katheter
DE69921764D1 (de) Katheter
NO995251D0 (no) FremgangsmÕte for administrering av haloterapi
DE69915677D1 (de) Vordrucksystem
FI974493A0 (fi) Arrangemang i samband med en hydraulisk slaganordning
NO974972L (no) FremgangsmÕte for Õ hindre brystcancer
FR2776660B1 (fr) Diazepino-indoles de phosphodiesterases iv
DE69912327D1 (de) Katheter
ATE276234T1 (de) Harnstoffderivate zur schmerzbekämpfung
FR2761589B1 (fr) Catheter, notamment pour neurochirurgie
NO991088D0 (no) SelvlÕsende kopling
TR199800403A3 (tr) a-Bromo-laktam türevlerinin hazirlanmasi için yöntem.
NO20002343L (no) FremgangsmÕte for Õ potensiere intravenøs estramustinfosfat
PT1051172E (pt) Metodo para tratamento da dpco
NO20005148L (no) FremgangsmÕte for Õ fremstille 4-substituerte-1H-indol-3- glyoksamider
FI981803A0 (fi) Menetelmä saostumien muodostumisen estämiseksi

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application